OncoSil Medical Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
3.00
6.70
21.40
29.10
39.90
Gross Income
3.00
6.70
21.40
29.10
39.90
SG&A Expense
4,690.50
5,651.70
8,851.40
10,780.60
13,049.20
EBIT
-
5,658.40
8,872.70
10,809.70
13,089.10
Unusual Expense
2,597.50
226.50
26.90
166.30
-
Non Operating Income/Expense
83.20
96.50
140.20
42.20
36.10
Pretax Income
7,179.50
5,636.20
8,601.50
10,462.30
12,980.50
Income Tax
314.60
2,757.20
3,832.90
3,446.20
4,440.90
Consolidated Net Income
6,864.80
2,879.00
4,768.60
7,016.10
8,539.50
Net Income
6,864.80
2,879.00
4,768.60
7,016.10
8,539.50
Net Income After Extraordinaries
6,864.80
2,879.00
4,768.60
7,016.10
8,539.50
Net Income Available to Common
6,864.80
2,879.00
4,768.60
7,016.10
8,539.50
EPS (Basic)
0.01
0.01
0.01
0.01
0.02
Basic Shares Outstanding
491,171.70
355,399.60
387,676.80
470,597.90
515,600.50
EPS (Diluted)
0.01
0.01
0.01
0.01
0.02
Diluted Shares Outstanding
491,171.70
355,399.60
387,676.80
470,597.90
515,600.50
EBITDA
4,690.50
5,651.70
8,851.40
10,780.60
13,049.20
Non-Operating Interest Income
194.70
152.20
158.00
223.40
144.80
About OncoSil Medical
View Profile
